Skip to content

Evaluation of the Therapeutic Efficacy of Acupuncture in Cognitive Impairment Associated with Diabetic Encephalopathy

Evaluation of the Therapeutic Efficacy of Acupuncture in Cognitive Impairment Associated with Diabetic Encephalopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002374
Enrollment
Unknown
Registered
2025-12-06
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment Associated with Diabetic Encephalopathy

Interventions

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Satisfaction of diagnostic criteria for diabetic cognitive impairment; 2) MMSE score greater than or equal to 10, and less than 27; MoCA score greater than or equal to 10, and less than 26; 3)Age greater than 65 and less than or equal to 75 years; 4)Clear mental status, stable vital signs, and the ability to cooperate in completing scale assessments; 5)Informed consent obtained from the patient or their immediate family members, who are willing to cooperate with the treatment.5)Informed consent obtained from the patient or their immediate family members, who are willing to cooperate with the treatment.

Exclusion criteria

Exclusion criteria: 1)Inability to participate in cognitive assessments due to visual impairment or aphasia; 2)Pre-existing cognitive impairment or a diagnosis of dementia prior to the onset of diabetes, or comorbidity with oncological diseases, systemic infections, or other neurological disorders, including Alzheimer's disease; 3)Inability to participate in the study due to psychiatric disorders, severe cognitive impairments, or emotional disturbances; 4)Presence of life-threatening conditions, including severe cardiovascular, respiratory, gastrointestinal, or urinary tract diseases; 5)Absence of a long-term cohabitant or caregiver to provide assistance; 6)Participation in clinical trials related to acupuncture or cognitive impairment within the past month.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Mini-Mental State Examination;Digit Span Test;Trail Making Test;Neuropsychiatric Inventory;Activities of Daily Living;Syndrome Differentiation Scale for Vascular Dementia;

Countries

China

Contacts

Public ContactPengwei Zhuang

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

zhuangpengwei@163.com13212082363

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026